Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
CytRx Corporation (NASDAQ: CYTR)
Sector: Medical
Current Price :
$2.31
52 Week Low
$1.63
52 Week High
$5.43
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
30M
Market Cap:
$0.08B
Avg Volume:
130016
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 5/16/2012 cytr split by factor of 0.140
1m
3m
6m
1y
2y
Opinion and Analysis
An Interesting, Volatile, Whippy Session
Jul 25, 2012 11:47 PM |
AAPL
,
ALTR
,
AMZN
,
ARMHY
,
CYTR
,
GRA
Cytrx (CYTR) Starts Combination Therapy Trial For Advanced Solid Tumors
Jul 25, 2012 10:40 AM |
CYTR
Very Nasty Day, Especially On The Nasdaq 100
Jun 26, 2012 12:55 AM |
AAPL
,
ALXA
,
AMZN
,
CYTR
,
FSIN
,
GOOG
More Articles on CYTR..
Press Releases
CytRx to Present at the Marcum MicroCap Conference
May 23, 2013 08:30 AM |
CYTR
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors
May 21, 2013 08:30 AM |
CYTR
CytRx Issues Letter to Stockholders Providing Business Update
May 20, 2013 08:30 AM |
CYTR
More Press Releases on CYTR..
SEC Filings
Form 4 CYTRX CORP For: Mar 12 Filed by: Patterson Scott Bradford (10K)
Mar 14, 2013 07:41 PM
Form 4 CYTRX CORP For: Mar 08 Filed by: KRIEGSMAN STEVEN A (10K)
Mar 12, 2013 03:59 PM
Form 4/A CYTRX CORP For: Dec 31 Filed by: LEVITT DANIEL J (10K)
Jan 07, 2013 05:50 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
CYTR
Compare to S&P
YTD
46.52 %
34.37 %
4 Weeks
-2.49 %
-2.39 %
12 Weeks
31.10 %
26.69 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-39.13 %
EPS Growth in Last Year:
-14.32 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
0.00 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##